Results 31 to 40 of about 3,850,355 (295)

Renal Tumors [PDF]

open access: yesAmerican Journal of Surgical Pathology, 2013
The International Society of Urological Pathology convened a consensus conference on renal cancer, preceded by an online survey, to address issues relating to the diagnosis and reporting of renal neoplasia. In this report, the role of biomarkers in the diagnosis and assessment of prognosis of renal tumors is addressed. In particular we focused upon the
Wei Huang   +133 more
openaire   +5 more sources

Cell-adhesion molecules and their soluble forms: Promising predictors of “tumor progression” and relapse in leukemia

open access: yesTumor Biology, 2018
Some surface markers are used to discriminate certain leukemic subpopulations that retain a greater oncogenic potential than others, and, for this reason, they were termed as leukemic stem cells, similar to the concept of cancer stem cells in carcinoma ...
Ieda Cristina Cunha Ferreira e Fonseca   +3 more
doaj   +1 more source

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

open access: yesScience, 2018
Mining immunotherapy clinical trials Clinical trial data can provide a wealth of information about how drugs work. Yet such information often belongs to pharmaceutical companies and is rarely accessible to the scientific community at large.
R. Cristescu   +23 more
semanticscholar   +1 more source

Serum biomarkers and clinical characteristics of patients with Hodgkin lymphoma [PDF]

open access: yesVojnosanitetski Pregled, 2018
Background/Aim. In classical Hodgkin’s lymphoma (cHL) the existing prognostic scoring systems do not include markers that adequately reflect the interaction of malignant Hodgkin and Reed-Sternberg (HRS) cells and tumor environment.
Simonović Olivera   +6 more
doaj   +1 more source

Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers

open access: yesMicromachines, 2020
The accurate determination of specific tumor markers associated with cancer with non-invasive or minimally invasive procedures is the most promising approach to improve the long-term survival of cancer patients and fight against the high incidence and ...
Jennifer Quinchia   +4 more
semanticscholar   +1 more source

Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer

open access: yesInternational Journal of Molecular Sciences, 2020
Although molecular mechanisms driving tumor progression have been extensively studied, the biological nature of the various populations of circulating tumor cells (CTCs) within the blood is still not well understood.
Y. Manjunath   +9 more
semanticscholar   +1 more source

Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors

open access: yesCancer Imaging, 2019
Purpose To identify clinically relevant magnetic resonance imaging (MRI) features of different types of metastatic brain lesions, including standard anatomical, diffusion weighted imaging (DWI) and dynamic susceptibility contrast (DSC) perfusion MRI ...
Ararat Chakhoyan   +7 more
doaj   +1 more source

Tumor-agnostic biomarkers

open access: yesPractical oncology, 2021
A huge amount of data obtained during last 30 years in multiple translational works allowed both to break particular tumor types into subgroups based on molecular markers but also to create pan-tumor subgroups based on particular markers. These evidence suggest the new approach to diagnostic and treatment algorithms should be implemented.
openaire   +1 more source

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI

open access: yesScientific Reports, 2022
This study aimed to differentiate isocitrate dehydrogenase (IDH) mutation status with the voxel-wise clustering method of multiparametric magnetic resonance imaging (MRI) and to discover biological underpinnings of the clusters.
Akifumi Hagiwara   +13 more
doaj   +1 more source

Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

open access: yesFrontiers in Immunology, 2022
The development and implementation of Immune Checkpoint Inhibitors (ICI) in clinical oncology have significantly improved the survival of a subset of cancer patients with metastatic disease previously considered uniformly lethal.
Agnete S. T. Engelsen   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy